SEC Filing Update: #QNCX Quince Therapeutics, Inc. : $34.35

Sector: Healthcare | YTD: 🔽 -94.28% The SEC disclosed Today (14-AUG-2026) that CORMORANT ASSET MANAGEMENT, LP has INCREASED #QNCX Shares by 1,864.88% 🟢 BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. * Previous Holdings: 5.50K Shares * Current Holdings: 108.03K Shares * Increase+102.53K * Increased(%)+1864.88% * Ownership: 9.99% * Estimated Investment Value: $3.11M https://www.thinksabio.com/reports/isr/QNCX 📌 Institutional activity in the last 30 days for #QNCX: • BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 27,732 shares (14-AUG-2026)